In a trial of WEGOVY injection in adult patients with type 2 diabetes and body mass index (BMI) greater than or equal to 27 kg/m2 for weight reduction (Study 3), hypoglycemia (defined as a plasma glucose less than 54 mg/dL) was reported in more patients treated with WEGOVY versus placebo [see Adverse Reactions (6.1)]
Unfortunately, the source of the product was not recorded in this cohort, so it is unclear whether compounding issues played a role in any adverse events seen
Bupropion SR is not the same as Bupropion XL
"I started at 285, Im approaching 180 now
However, GLP-1 receptors are also found in the brain, where they influence mood, stress response, and even neurotransmitter levels
The injection timing is flexible, not linked to meals